Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Krystexxa

Pegloticase

Open in the dashboard

Part D claims

3,656

Prescriptions dispensed, refills included

Drug cost

$156,245,093

Paid at the pharmacy, in all

Prescribers

163

With 11 or more claims of it

In 2024, Medicare Part D recorded 3,656 claims for Krystexxa (pegloticase) from 163 prescribers, at a total drug cost of $156.2 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 28 states and territories
Part D claims for Krystexxa by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
GA 26 569 $19,435,227
TX 15 523 $27,345,800
CA 19 491 $25,097,063
HI 10 227 $6,609,095
NC 9 221 $8,482,420
NY 8 196 $9,040,247
FL 10 196 $10,083,580
TN 5 190 $5,468,099
PA 7 177 $8,730,022
MS 10 177 $5,375,182
NJ 6 89 $4,708,077
AR 4 72 $2,036,272
AZ 4 63 $3,932,740
VA 3 57 $3,279,115
IL 3 55 $1,793,603
The other 13 states and territories
State Prescribers Claims Drug cost
MI 3 46 $1,337,069
OH 3 45 $1,630,243
AL 2 39 $1,846,738
LA 3 37 $1,114,440
MD 2 28 $1,539,749
KY 2 27 $1,156,602
WV 2 27 $1,147,400
OK 2 24 $1,101,810
CT 1 20 $905,845
DC 1 20 $1,230,406
SC 1 17 $907,864
NV 1 12 $297,390
MO 1 11 $612,997

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 13 of 13
Part D claims for Krystexxa by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Rheumatology 51 1,239 $57,445,576
Nephrology 50 1,197 $51,344,508
Internal Medicine 22 486 $18,628,486
Nurse Practitioner 14 279 $11,010,511
Podiatry 10 164 $5,884,672
Family Practice 5 123 $4,467,409
Physician Assistant 3 44 $1,964,246
Infectious Disease 2 27 $909,142
Medical Oncology 1 24 $1,393,665
Hematology-Oncology 2 24 $1,038,257
Endocrinology 1 22 $625,978
Neurology 1 15 $839,559
Allergy/ Immunology 1 12 $693,084

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Elvin Garcia Rheumatology TX 230 $13,732,442 $11,229
Sunil Patel Nephrology CA 99 $5,413,334 $93,129
Shree Mulay Nephrology TN 87 $2,510,355 $5,959
Victor Carabello Internal Medicine CA 78 $4,392,908 $38,399
James Hunt Rheumatology GA 71 $2,489,760 $14,723

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record